Mike Bruff - Varian Medical Vice president, IR Contact Officer

President

Mike Bruff is Vice president, IR Contact Officer of Varian Medical Systems since 2018.
Tenure 6 years
Phone650 493-4000
Webwww.varian.com

Varian Medical Management Efficiency

The company has Return on Asset of 5.92 % which means that on every $100 spent on assets, it made $5.92 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 13.51 %, implying that it generated $13.51 on every 100 dollars invested. Varian Medical's management efficiency ratios could be used to measure how well Varian Medical manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 350.5 M in debt with debt to equity (D/E) ratio of 0.16, which may show that the company is not taking advantage of profits from borrowing. Varian Medical Systems has a current ratio of 1.48, which is typical for the industry and considered as normal. Debt can assist Varian Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Varian Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Varian Medical Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Varian to invest in growth at high rates of return. When we think about Varian Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 9 records

PRESIDENT Age

Toshiyasu IiyamaNomura Holdings ADR
59
Kenji KimuraNomura Holdings ADR
N/A
Lawrence RipsherPinterest
42
Omkar HaladyIris Acquisition Corp
39
Toshio MoritaNomura Holdings ADR
58
Jordan RuddyBluerock Homes Trust
61
Tomoyuki TeraguchiNomura Holdings ADR
62
Shoichi NagamatsuNomura Holdings ADR
60
Masahiko MaekawaNomura Holdings ADR
41
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company was founded in 1948 and is headquartered in Palo Alto, California. Varian Medical operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10000 people. Varian Medical Systems (VAR) is traded on New York Stock Exchange in USA and employs 10,000 people.

Management Performance

Varian Medical Systems Leadership Team

Elected by the shareholders, the Varian Medical's board of directors comprises two types of representatives: Varian Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Varian. The board's role is to monitor Varian Medical's management team and ensure that shareholders' interests are well served. Varian Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Varian Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Laret, Independent Director
Regina Dugan, Independent Director
Jose Baselga, Director
Erich Reinhardt, Independent Director
Timothy Guertin, Independent Vice Chairman of the board
Kolleen Kennedy, Executive Vice President, President - Proton Solutions Division and Chief Growth Officer
J Bruff, Chief Financial Officer, Senior Vice President - Finance
Anat Ashkenazi, Independent Director
Susan Bostrom, Independent Director
JeanLuc Butel, Independent Director
Kevin OReilly, Senior Vice President and President Oncology Systems
Sunny Sanyal, Sr. VP and President of Imaging Components Bus.es
Dow Wilson, President, Chief Executive Officer, Director
Francis Facchini, President Interventional Solutions Business
Clarence Verhoef, Senior Vice President - Finance, Corporate Controller
Jeffrey Balser, Independent Director
R Eckert, Independent Chairman of the Board
Venkatraman Thyagarajan, Independent Director
Anshul Maheshwari, Vice President Treasurer, IR Contact Officer
David Illingworth, Independent Director
Judy Bruner, Independent Director
Gary Bischoping, Chief Financial Officer, Senior Vice President - Finance
Juarez Monroeas, Senior Vice President - Human Resources and Chief People Officer
Elisha Finney, CFO and Executive VP of Fin.
John Kuo, Senior Vice President, General Counsel, Corporate Secretary
Rafael Torres, Senior Vice President - Business Development and Strategy
Christopher Toth, President, Chief Executive Officer, Chief Operating Officer
Mike Bruff, Vice president, IR Contact Officer
Michael Hutchinson, Senior Vice President, Chief Legal Officer, Corporate Secretary
Andrew Eckert, Independent Chairman of the Board
Phillip Febbo, Chief Medical Officer, Director
Spencer Sias, Vice President - Corporate Communications and Investor Relations
Chris Toth, President - Varian Oncology Systems
Ruediger NaumannEtienne, Independent Director
Michelle Beau, Independent Director

Varian Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Varian Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Varian Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Varian Medical's short interest history, or implied volatility extrapolated from Varian Medical options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Varian Medical Systems information on this page should be used as a complementary analysis to other Varian Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in Varian Stock

If you are still planning to invest in Varian Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Varian Medical's history and understand the potential risks before investing.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope